• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Pennsylvania Names Ophelia First Virtual-First Opioid Use Disorder Center of Excellence

by Jasmine Pennic 04/17/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Ophelia, a leading provider of virtual care for opioid use disorder (OUD), has been designated as a Center of Excellence (COE) by Pennsylvania’s Department of Human Services. 

– The milestone achievement makes Ophelia the first statewide and virtual-first COE in the state, offering a critical new access point for Pennsylvanians battling addiction. By offering a virtual-first treatment model, Ophelia complements existing resources and expands access to life-saving care for thousands of Pennsylvanians struggling with OUD.

Addressing Pennsylvania’s Public Health Crisis

The opioid epidemic continues to devastate Pennsylvania, claiming the lives of an average of 14 residents daily. This number tragically surpasses the national average by a factor of two. The COVID-19 pandemic and the rise of synthetic opioids like fentanyl have further exacerbated overdose deaths in recent years.

Ophelia’s Virtual-First Model Increases Access to Treatment

In response to this crisis, Pennsylvania established the COE program in 2016. It aims to break down barriers to comprehensive care for patients with OUD and increase access to medication-assisted treatment (MAT), a proven therapy that can reduce overdose deaths by 76%. Ophelia’s COE designation signifies that their virtual-first care model meets the program’s rigorous standards for evidence-based treatment.

Virtual Care: Effective, Accessible, and Lifesaving

Ophelia’s virtual-first approach removes geographical and logistical barriers typically associated with traditional in-person treatment. This model aligns with federal guidance from the CDC, NIH, and CMS, which confirms the effectiveness of telehealth in treating OUD. For patients who may be hesitant or unable to access in-person care, Ophelia provides a crucial lifeline.

Improved Outcomes and Cost Savings

Studies have shown that patients, especially those on Medicaid, are 50% more likely to remain in treatment for six months when connected with in-network providers like Ophelia. This continuity of care not only translates to improved patient outcomes but also leads to cost savings for payors.

Ophelia’s Commitment to Quality Care

Ophelia provides patients with a safe and convenient way to access treatment. Patients can connect with clinicians from the comfort of their homes and schedule appointments that fit their busy schedules, including evenings and weekends. Additionally, clinicians and care coordinators are available seven days a week to offer support, address treatment challenges, and collaborate with external providers. All Ophelia clinicians are addiction medicine specialists, employed by the company, and licensed in the patient’s state.

“The Centers of Excellence were designed as a patient-centered model of care that sought to make treatment and recovery an accessible, approachable, and sustainable part of a person’s life,” said Human Services Secretary Dr. Val Arkoosh. “A virtual-first approach to this treatment gives us more opportunities to meet people where they are and get them the life-saving care they deserve. We are encouraged that a medical practice can see the value of this model and are using it to pursue further innovation, and we look forward to assessing the impact Ophelia’s approach to our Centers of Excellence Model can have on Pennsylvanians affected by the disease of addiction.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Opioid Epidemic, Opioid Prescriptions

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |